Your doctor needs to confirm you met ONE of these criteria when you first started taking a GLP-1: Path 1: Higher BMI BMI of 35 or higher No other health conditions required Example: You started Wegovy in 2024 with BMI 37, and now your BMI is 33 you still qualify
[2] [3] This medication represents a novel therapeutic approach that targets two incretin hormone pathways simultaneously, offering enhanced glycemic control and significant weight reduction compared to single-receptor agonists
An attorney can help determine the viability and value of your case
Even with reduced appetite, some people unconsciously compensate with calorie-dense foods
Patients who suffered adverse gastrointestinal issues after taking Trulicity may qualify for compensation by taking legal action
Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)-a multicentre, double-blind, randomised, placebo-controlled trial